An observational study in Superficial Dyspareunia, sponsored by Université de Reims Champagne-Ardenne. Not yet recruiting at 2 sites in France. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-22.
Sponsored by Université de Reims Champagne-Ardenne · Observational
Superficial dyspareunia are persistent or recurrent pains during an attempt at sexual intercourse or during effective penetration.
They affect between 3 to 18% of women and are a source of physical and psychological suffering.
Some health professionals (gynecologists, general practitioners, midwives) are confronted daily with these complaints.
The approach of sexuality remains a complex subject even within the medical field. As a result, communication between women and health professionals can be difficult, leading to delayed diagnosis or inadequate management.
The main objective is to describe the management of superficial dyspareunia by health professionals.
158 studies on the registry are indexed under Dyspareunia; 40 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 165 across 30 observational studies indexed under Dyspareunia.
Browse Dyspareunia studies →Université de Reims Champagne-Ardenne is the lead sponsor of 64 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with superficial dyspareunia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Superficial dyspareunia, i.e.:
Exclusion Criteria:
Adult women, having sexual activity with or without vaginal penetration, suffering from superficial dyspareunia, whether or not managed by health professionals.
Other: Data collection
data collection
medical history
Question to the woman about possible pain during sexual intercourses by an health professional (yes or no)
Time frame: Day 0
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université de Reims Champagne-Ardenne